Zhitong Finance App News, Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) issued an announcement. Recently, the company received the “Drug Registration Certificate” for dagliflozin tablets approved and issued by the State Drug Administration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.